Research Peptide Comparison
Retatrutide 10mg and Retatrutide 40mg are both GLP-1 Peptides research peptides available from Neovia Peptides. This comparison highlights the key differences in specifications, pricing, and availability to help inform your research decisions.
Retatrutide is a 39-amino-acid synthetic peptide that functions as a triple agonist at the GLP-1, GIP and glucagon receptors. By engaging all three incretin and glucagon pathways at once, it has been investigated for its combined effects on insulin secretion, energy expenditure, lipolysis and hepatic glucose output, and is one of the most-studied triple agonists in modern metabolic research.
Compared to Retatrutide 40mg, Retatrutide 10mg is priced at £69.50 with 99%+ verified purity. Its CAS registry number is 2381089-83-2. It has a molecular weight of 4875.42 g/mol.
Retatrutide 10mg is available in 10mg, 20mg, 40mg and ships with a full Certificate of Analysis from Janoshik Analytical. At £129.50 less than Retatrutide 40mg, it is the more affordable option in this comparison.
Retatrutide is a synthetic peptide that simultaneously activates the GLP-1, GIP and glucagon receptors, producing combined incretin and glucagon-axis engagement in a single molecule. This triple-agonist mechanism underpins its role in research into metabolic flexibility, energy expenditure and pancreatic hormone signalling, and has established it as one of the most-studied triple agonists in modern metabolic research.
Compared to Retatrutide 10mg, Retatrutide 40mg is priced at £199.00 with 99%+ verified purity. Its CAS registry number is 2381089-83-2. It has a molecular weight of 4875.42 g/mol.
Retatrutide 40mg is available in 10mg, 20mg, 40mg and ships with a full Certificate of Analysis from Janoshik Analytical. It is priced £129.50 higher than Retatrutide 10mg.
All products sold by Neovia Peptides are strictly for in-vitro research and laboratory use only. Not intended for human or veterinary use, food additives, drugs, or cosmetics. By purchasing from this website, you agree that you understand and accept these terms.
